Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog).

Full Abstract

AIMS: The use of insulin lispro in pregnancy has not been systematically investigated despite its increasing use. Pooled data from seven centres with experience in the use of insulin lispro were accumulated to evaluate pregnancy outcome in women with Type 1 diabetes. METHODS: Seven units with specialist obstetric diabetes services were recruited to describe their total experience with insulin lispro in pregnancy. Outcomes with respect to the rate of miscarriage, congenital abnormality, perinatal mortality and maternal parameters were recorded in a standardized format. RESULTS: Outcomes on 71 babies from 76 pregnancies were documented. There were six (7.8%) early miscarriages. All 71 babies were liveborn with a mean gestational age of 37.2 weeks, and median birthweight of 3230 g. Seven babies weighed > 4 kg. There were four congenital abnormalities (5.6%). There was a 72% increase in the mean insulin dose (0.75-1.29 IU/kg per day). Maternal glycaemic control improved throughout pregnancy. No women developed retinopathy de novo during pregnancy and six with established retinopathy required laser therapy during pregnancy. CONCLUSIONS: The use of insulin lispro in Type 1 diabetes during pregnancy results in outcomes comparable to other large studies of diabetic pregnancy.

Author information

Author/s: Masson, E A (EA); Patmore, J E (JE); Brash, P D (PD); Baxter, M (M); Caldwell, G (G); Gallen, I W (IW); Price, P A (PA); Vice, P A (PA); Walker, J D (JD); Lindow, S W (SW);

Affiliation: Diabetes Centre, The Michael White Center for Diabetes & Endocrinology, Hull Royal Infirmary, Hull, UK.

Journal and publication information

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal: Diabetic medicine : a journal of the British Diabetic Association (Diabet Med), published in England. (Language: eng)

Reference: 2003-Jan; vol 20 (issue 1) : pp 46-50

Dates: Created 2003/01/09; Completed 2003/03/24; Revised 2006/11/15;

PMID: 12519319, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: 18 Feb 2009 00:00:00)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.